pharmaglobenews

pharmaglobenews

Atrial Fibrillation Market Set to Witness Significant Growth Driven by Rising Prevalence, Technological Advancements, and Expanding Therapeutic Options Through 2034

Atrial Fibrillation Market Summary The atrial fibrillation therapeutics market is expected to increase substantially across the 7MM during the forecast period (2025–2034), driven by major drivers such as the rising prevalent population, technological advancements, and upcoming therapies. In the United States, the
30 June 2026

Japan Healthcare Outlook Report, 2025 by Delveinsight

DelveInsight’s “Japan Healthcare Outlook Report, 2025” provides comprehensive insights about the healthcare scenario, regulatory policies, and reimbursement landscape in Japan. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country.
29 June 2026

Progressive Multifocal Leukoencephalopathy Pipeline Insights Accelerates as 3+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Progressive Multifocal Leukoencephalopathy Pipeline Insight 2026” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Progressive Multifocal Leukoencephalopathy pipeline landscape. It covers the Progressive Multifocal Leukoencephalopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers
24 June 2026
1 2 3 4 5 6 30